Therapeutic combination of amlodipine and benazepril/benazeprilat
作者： Alan Edward Royce , William Lionel Daley , Ann Reese Comfort , Randy Lee Webb , William Shifeng Wei
DOI:
关键词:
摘要: The present invention especially relates to the use of a combination comprising (1) an ACEI selected from group consisting benazepril, benazeprilat, and pharmaceuticall acceptable salts thereof, (2) amlodipine or pharmaceutically salt for manufacture medicament treatment prevention delay progression condition hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular stroke, pulmonary disease hypertension headache; wherein (i) amount thereof corresponds 6 about mg 40 free base (ii) ACE inhibitor 20 160 benazepril hydrochloride.
lens.org 参考文章(9)
Robert L. Jerzewski, Faranak Nikfar, Nemichand B. Jain, Abu T. M. Serajuddin, Pharmaceutical compositions having good dissolution properties ,(1995)
Maria Kiraly nee Ignacz, Attila Mandi, Pal Fekete, Gizella Kiss nee Szabo, Maria Krisztian, Imre Klebovich, Sandor Drabant, Zsuzsanna Jambor nee Hoffmann, Gabor Sipos, Erzsebet Barczay, Gyorgy Ujfalussy, Magdolna Gora nee Hernyes, Diffusion-osmotic controlled drug-release pharmaceutical composition and process for preparing same ,(1994)
Marc M. J. Henis, Joseph Papa, Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor ,(1992)
Michelle K. Bazil, Randy L. Webb, Hemodynamic effects of amlodipine and benazeprilat in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. ,vol. 21, pp. 405- 411 ,(1993) , 10.1097/00005344-199303000-00009
Emilio Kuschnir, Enzo Acuña, David Sevilla, Jesús Vasquez, Mario Bendersky, Jorge Resk, Robert Glazer, Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo Clinical Therapeutics. ,vol. 18, pp. 1213- 1224 ,(1996) , 10.1016/S0149-2918(96)80076-2
Franz H Messerli, Suzanne Oparil, Zhanbin Feng, Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. American Journal of Cardiology. ,vol. 86, pp. 1182- 1187 ,(2000) , 10.1016/S0002-9149(00)01199-1
Alan A. Boulton, Peter H. Yu, Bruce A. Davis, Aliphatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents ,(1992)
M. R. Weir, Effects of low dose combination therapy with amlodipine/benazepril on systolic blood pressure Cardiovascular reviews and reports. ,vol. 20, pp. 368- 374 ,(1999)